According to researchers who are advocating the development and need of a triple inhaler, triple inhaled therapy (two bronchodilators and a steroid) is highly effective for treating COPD patients.

Study leader Professor Jadwiga Wedzicha, head of respiratory medicine at the Royal Free and University College Medical School in London, said that the findings are some of the most interesting results of all as all the concerned drugs have varying and possible synergistic clinical activities.

From Pulsetoday.co.uk:

Data from the INSPIRE trial, comparing salmeterol/fluticasone with tiotropium in 1,323 patients with severe COPD found exacerbation rates were similar between the two groups.

But the nature of the exacerbations seemed to differ between the two groups. Patients who suffered an exacerbation while using salmeterol/fluticasone were more likely to need antibiotics while thos eon tiotropium tended to be treated with steroids.

Study leader Professor Jadwiga Wedzicha, head of respiratory medicine at the Royal Free and University College Medical School in London, said: ‘This is possibly the most interesting result of all - that these drugs have different and possibly synergistic clinical activity.’

The study is expected to offer a new paradigm for helping COPD patients fight strongly against COPD, one of the most common ailments all over the world.

Bookmark It

Hide Sites

Tags: bronchodilators, COPD, steroid, synergistic clinical activities, triple inhaled therapy

Posted in Steroid Cycles, Steroids and Anabolic Steroids, buy steroids, steroid nation